STALEY CAPITAL ADVISERS’s Matinas BioPharma MTNB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8,000	Closed	-$63.3K	–	188
2024 Q2	$63.3K	Hold	8,000	–	–	﹤0.01%	178
2024 Q1	$108K	Hold	8,000	–	–	0.01%	179
2023 Q4	$86.5K	Hold	8,000	–	–	﹤0.01%	175
2023 Q3	$52K	Sell	8,000 -4,000	-33%	-$49.1K	﹤0.01%	174
2023 Q2	$216K	Hold	12,000	–	–	0.01%	166
2023 Q1	$282K	Hold	12,000	–	–	0.02%	154
2022 Q4	$300K	Hold	12,000	–	–	0.02%	138
2022 Q3	$382K	Hold	12,000	–	–	0.02%	123
2022 Q2	$474K	Hold	12,000	–	–	0.03%	118
2022 Q1	$483K	Hold	12,000	–	–	0.02%	124
2021 Q4	$606K	Hold	12,000	–	–	0.03%	118
2021 Q3	$780K	Hold	12,000	–	–	0.04%	108
2021 Q2	$465K	Hold	12,000	–	–	0.02%	127
2021 Q1	$630K	Hold	12,000	–	–	0.04%	116
2020 Q4	$816K	Hold	12,000	–	–	0.05%	100
2020 Q3	$460K	Hold	12,000	–	–	0.03%	117
2020 Q2	$464K	Buy	12,000 +2,000	+20%	+$76.7K	0.03%	111
2020 Q1	$300K	Hold	10,000	–	–	0.03%	118
2019 Q4	$1.14M	Buy	10,000 +2,000	+25%	+$116K	0.08%	94
2019 Q3	$252K	Buy	8,000 +4,000	+100%	+$145K	0.02%	147
2019 Q2	$171K	Buy	+4,000	New	+$192K	0.01%	171